• Corpus ID: 212514538

Development of Rutin Suspension and Evaluation of Corneal Permeation across the Goat Cornea

@inproceedings{Kumar2017DevelopmentOR,
  title={Development of Rutin Suspension and Evaluation of Corneal Permeation across the Goat Cornea},
  author={Chelladurai Senthil Kumar and Ponnusamy Chandra Sekar and Shanmugam Palaniappan Sharavanan and Chandrasekar Narendhar and Natesan Subramanian},
  year={2017}
}
Rutin, a bioflavonoid drug of natural origin, has significant antioxidant and anti-inflammatory property and can decrease the intraocular pressure. The present research work is aimed to formulate rutin suspension and to evaluate the corneal permeation of rutin. Rutin suspension has been formulated by using suspending agent and homogenizer. The formulated drug containing suspension were characterized for average particle size, zeta potential, polydispersity index, pH, in-vitro drug release and… 

References

SHOWING 1-10 OF 17 REFERENCES

Development of O/W nanoemulsions for ophthalmic administration of timolol.

Effect of hydroxypropyl beta cyclodextrin complexation on aqueous solubility, stability, and corneal permeation of acyl ester prodrugs of ganciclovir

Results indicate the presence of an unstirred aqueous diffusion layer at the corneal surface that restricts the transport of the highly lipophilic GCV dibutyrate prodrug across cornea.

Corneal permeation of ganciclovir: mechanism of ganciclovir permeation enhancement by acyl ester prodrug design.

  • G. TirucheraiC. DiasA. Mitra
  • Biology
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
  • 2002
Overall prodrug permeability correlated linearly with increased susceptibility of the GCV esters to undergo hydrolysis in the cornea, indicating that the ideal prodrug is one that not only possesses enhanced partitioning characteristics, but also high enzyme susceptibility.

Transcorneal Iontophoresis for Delivery of Ciprofloxacin Hydrochloride

The ability of iontophoresis to rapidly drive ciprofloxacin into the cornea where a drug reservoir is formed, which eventually releases slowly into aqueous humor, eliciting sustained therapeutic effect is unveiled.

A potential new therapeutic system for glaucoma: solid lipid nanoparticles containing methazolamide

Formulation of MTA–SLNs would be a potential delivery carrier for ocular delivery, with the advantages of a more intensive treatment for glaucoma, lower in doses and better patient compliance compared to the conventional eye drops.

Corneal absorption and anterior chamber pharmacokinetics of dipeptide monoester prodrugs of ganciclovir (GCV): in vivo comparative evaluation of these prodrugs with Val-GCV and GCV in rabbits.

  • Sriram GundaS. HariharanA. Mitra
  • Medicine, Biology
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
  • 2006
YVGCV and VV GCV exhibited superior corneal absorption and bioavailability, in comparison with GVGCv, VGCV, and GCV, which may be a result of a combination of transcellular passive diffusion and peptide transporter (PEPT1)-mediated transport across the cornean epithelium.

Colloidal carriers for ophthalmic drug delivery.

This review will discuss recent progress and specific development issues relating to colloidal drug delivery systems, such as liposomes, niosomes, nanoparticles, and microemulsions in ocular drug delivery, and the benefits of using colloidal carriers in intravitreal injections for posterior drug delivery.

Ocular drug delivery systems: An overview.

Current review intends to summarize the existing conventional formulations for ocular delivery and their advancements followed by current nanotechnology based formulation developments.

Recent trends in ocular drug delivery

Modern discovery techniques are leading to an ever increasing numbers of drugs and drug candidates. Together with the deeper understanding of ocular physiological processes and the molecular